- Home
- AIR vs NAMS Comparison
AIR vs NAMS Comparison
Compare AIR & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIR
- NAMS
- Stock Information
- Founded
- AIR 1951
- NAMS 2019
- Country
- AIR United States
- NAMS Netherlands
- Employees
- AIR N/A
- NAMS N/A
- Industry
- AIR Aerospace
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- AIR Industrials
- NAMS Health Care
- Exchange
- AIR Nasdaq
- NAMS Nasdaq
- Market Cap
- AIR 2.2B
- NAMS 2.2B
- IPO Year
- AIR 1988
- NAMS N/A
- Fundamental
- Price
- AIR $61.39
- NAMS $18.11
- Analyst Decision
- AIR Strong Buy
- NAMS Strong Buy
- Analyst Count
- AIR 6
- NAMS 6
- Target Price
- AIR $80.67
- NAMS $42.83
- AVG Volume (30 Days)
- AIR 204.1K
- NAMS 694.5K
- Earning Date
- AIR 07-17-2025
- NAMS 05-08-2025
- Dividend Yield
- AIR N/A
- NAMS N/A
- EPS Growth
- AIR N/A
- NAMS N/A
- EPS
- AIR N/A
- NAMS N/A
- Revenue
- AIR $2,682,500,000.00
- NAMS $47,140,000.00
- Revenue This Year
- AIR $18.46
- NAMS N/A
- Revenue Next Year
- AIR $5.10
- NAMS N/A
- P/E Ratio
- AIR N/A
- NAMS N/A
- Revenue Growth
- AIR 21.07
- NAMS 586.97
- 52 Week Low
- AIR $46.51
- NAMS $14.06
- 52 Week High
- AIR $76.34
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- AIR 56.95
- NAMS 47.80
- Support Level
- AIR $58.83
- NAMS $16.79
- Resistance Level
- AIR $63.20
- NAMS $19.58
- Average True Range (ATR)
- AIR 1.42
- NAMS 0.94
- MACD
- AIR 0.04
- NAMS -0.12
- Stochastic Oscillator
- AIR 58.67
- NAMS 47.07
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.